Proportion of the target population who received 3 doses in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)

Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand): Proportion of the target population who received 3 doses was 94.0% in 2024. ▬ Flat

Latest (2024)
94.0%
Change on year
unchanged
Rank
2nd
of 36 groups
All-time high
96.0%
in 2004
All-time low
93.0%
in 2000
Years of data
25
2000–2024

Proportion of the target population who received 3 doses of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand), 2000–2024

0204060801002000201220242000: 93 %2001: 95 %2002: 95 %2003: 95 %2004: 96 %2005: 96 %2006: 96 %2007: 96 %2008: 96 %2009: 95 %2010: 94 %2011: 94 %2012: 95 %2013: 94 %2014: 93 %2015: 93 %2016: 93 %2017: 93 %2018: 94 %2019: 94 %2020: 94 %2021: 94 %2022: 94 %2023: 94 %2024: 94 %

Source: United Nations Statistics Division, SDG Global Database. Measured in %.

Analysis

Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) recorded 94.0% for proportion of the target population who received 3 doses of in 2024.

Compared with earlier readings it is up 1.1% over ten years.

Over the whole period, proportion of the target population who received 3 doses of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) peaked at 96.0% in 2004 and was at its lowest, 93.0%, in 2000.

Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 2nd of 36 groups on this measure, in the top 10%.

Proportion of the target population who received 3 doses in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand), year by year

Annual values for Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%) in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand), 2000 to 2024.
Year % Change
2000 93.0% —
2001 95.0% +2.2%
2002 95.0% +0.0%
2003 95.0% +0.0%
2004 96.0% +1.1%
2005 96.0% +0.0%
2006 96.0% +0.0%
2007 96.0% +0.0%
2008 96.0% +0.0%
2009 95.0% -1.0%
2010 94.0% -1.1%
2011 94.0% +0.0%
2012 95.0% +1.1%
2013 94.0% -1.1%
2014 93.0% -1.1%
2015 93.0% +0.0%
2016 93.0% +0.0%
2017 93.0% +0.0%
2018 94.0% +1.1%
2019 94.0% +0.0%
2020 94.0% +0.0%
2021 94.0% +0.0%
2022 94.0% +0.0%
2023 94.0% +0.0%
2024 94.0% +0.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 95.3% 93.0% 96.0% 10
2010s 93.7% 93.0% 95.0% 10
2020s 94.0% 94.0% 94.0% 5

Countries ranked near Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)

  1. 1 Antigua and Barbuda 99.0% compare
  2. 1 Brunei Darussalam 99.0% compare
  3. 1 Costa Rica 99.0% compare
  4. 1 Cuba 99.0% compare
  5. 1 Democratic People's Republic of Korea 99.0% compare
  6. 1 Hungary 99.0% compare
  7. 1 Jamaica 99.0% compare
  8. 1 Japan 99.0% compare
  9. 1 Kuwait 99.0% compare
  10. 1 Luxembourg 99.0% compare
  11. 1 Maldives 99.0% compare
  12. 1 Monaco 99.0% compare
  13. 1 Nauru 99.0% compare
  14. 1 Niue 99.0% compare
  15. 1 Oman 99.0% compare
  16. 1 Portugal 99.0% compare
  17. 1 Saint Lucia 99.0% compare
  18. 1 Saint Vincent and the Grenadines 99.0% compare
  19. 1 Tonga 99.0% compare
  20. 1 Türkiye 99.0% compare
  21. 1 Brunei 99.0% compare
  22. 1 Turkey 99.0% compare
  23. 1 Naoero 99.0% compare

See the full ranking of 247 places →

More infrastructure data for Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)

All data for Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) →

Frequently asked questions

What is proportion of the target population who received 3 doses of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
Proportion of the target population who received 3 doses of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) was 94.0% in 2024, according to United Nations Statistics Division, SDG Global Database.
What is the highest proportion of the target population who received 3 doses of recorded in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
The highest recorded value was 96.0% in 2004.
What is the lowest proportion of the target population who received 3 doses of recorded in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
The lowest recorded value was 93.0% in 2000.
How does Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) rank for proportion of the target population who received 3 doses of?
Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) ranks 2nd out of 36 groups with data for 2024.
Is proportion of the target population who received 3 doses of rising or falling in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)?
Over the last ten years it is up 1.1%. The long-run trend across the full record is flat.
Where does this Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand) data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Proportion of the target population who received 3 doses of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand). Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 07 November 2026, from https://infrastructure.statizoid.com/stat/proportion-of-the-target-population-who-received-3-doses-of-diphtheria-tetanus-pertussis/developed-regions-europe-cyprus-israel-northern-america-japan-australia-and-new-zealand/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://infrastructure.statizoid.com/stat/proportion-of-the-target-population-who-received-3-doses-of-diphtheria-tetanus-pertussis/developed-regions-europe-cyprus-israel-northern-america-japan-australia-and-new-zealand/">Proportion of the target population who received 3 doses of in Developed regions (Europe, Cyprus, Israel, Northern America, Japan, Australia & New Zealand)</a> — Statizoid

About this data

Indicator
Proportion of the target population who received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccine (%)
Unit
%
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
247 places, 6,154 data points, 2000–2024
Last refreshed